Check the Batch

RECALLING FIRM / COMPANY

Atlantic Pro Nutrients, Inc. dba XYMOGEN Recalls

Are there any recent FDA recalls involving Atlantic Pro Nutrients, Inc. dba XYMOGEN?

0 recall records initiated in the snapshot’s last 365 days. 0 are FDA-listed ongoing with no termination date.FDA data updated September 16, 2026 · Snapshot assessed September 18, 2026

The FDA identifies this company as the recalling firm; this does not establish that it is the manufacturer, retailer or brand owner. “Recent ongoing” means initiated within 365 days of September 18, 2026, FDA status “Ongoing,” and no termination date. This snapshot cannot confirm what is active today.

3 FDA product recordsLatest initiation: Aug 16, 2013

Same product name.
Different batch.
Check the label.

Latest recalls involving Atlantic Pro Nutrients, Inc. dba XYMOGEN

Most recently initiated in the available FDA data; these are not necessarily active recalls.

Aug 16, 2013 · FDA status: TerminatedXYMOGEN LipiChol (Omega-3 Phospholipid 540 mg) Medical FoodProduct was labeled as a medical food as opposed to a dietary supplement.View recall details →Aug 16, 2013 · FDA status: TerminatedLipiChol 540 (Omega-3 Phospholipid) Medical Food Dispense by PrescriptionProduct was labeled as a medical food as opposed to a dietary supplement.View recall details →May 1, 2013 · FDA status: TerminatedXYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy…Undeclared Soy and Milk on the label.View recall details →

Earlier recall history

3 records initiated before 2026. Browse the history below or choose a year.

2013 (3)

All FDA recall records involving Atlantic Pro Nutrients, Inc. dba XYMOGEN

Latest and historical records, ordered by initiation date (newest first). FDA status appears on each record.

3 recall recordsPage 1 of 1
Class III
FDA status: Terminated

XYMOGEN LipiChol (Omega-3 Phospholipid 540 mg) Medical Food

Product was labeled as a medical food as opposed to a dietary supplement.

OtherView details →
Class III
FDA status: Terminated

LipiChol 540 (Omega-3 Phospholipid) Medical Food Dispense by Prescription

Product was labeled as a medical food as opposed to a dietary supplement.

OtherView details →
Class I
FDA status: Terminated

XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and…

Undeclared Soy and Milk on the label.

Undeclared allergenView details →

Found your product? Now check the codes.

Same product name. Different batch. Details matter.

→